PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,504 | -12.9% | 4,066 | -9.0% | 0.04% | -10.4% |
| Q2 2023 | $80,978 | -42.3% | 4,469 | -15.3% | 0.05% | -37.7% |
| Q1 2023 | $140,421 | -0.5% | 5,279 | -27.7% | 0.08% | +4.1% |
| Q4 2022 | $141,167 | +96.1% | 7,303 | -28.6% | 0.07% | +131.2% |
| Q1 2022 | $72,000 | -50.7% | 10,224 | -5.6% | 0.03% | -41.8% |
| Q4 2021 | $146,000 | +33.9% | 10,827 | +67.4% | 0.06% | +14.6% |
| Q3 2021 | $109,000 | -44.9% | 6,466 | -4.9% | 0.05% | -40.7% |
| Q2 2021 | $198,000 | -54.1% | 6,799 | -37.9% | 0.08% | -55.5% |
| Q1 2021 | $431,000 | +76.6% | 10,950 | +1.8% | 0.18% | +80.2% |
| Q4 2020 | $244,000 | – | 10,759 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |